Biodesix
BDSX
HK$3.05
Share price
-6.93%
Change (1 day)
-77.20%
Change (1 year)
Categories
Revenue for Biodesix (BDSX)
Revenue in 2025 (TTM): HK$0.57 Billion
According to Biodesix's latest financial reports the company's current revenue (TTM 
) is HK$0.58 Billion. In 2024 the company made a revenue of HK$0.55 Billion an increase over the revenue in the year 2023 that were of HK$0.38 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biodesix from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | HK$0.57 B | 4.64% |
| 2024 | HK$0.55 B | 44.43% |
| 2023 | HK$0.38 B | 28.41% |
| 2022 | HK$0.29 B | -29.75% |
| 2021 | HK$0.42 B | 20.34% |
| 2020 | HK$0.35 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OpGen
OPGN | HK$9.93 M | -98.30% | 🇺🇸 USA |
 NeoGenomics
NEO | HK$5.27 B | 802.95% | 🇺🇸 USA |
 LabCorp LH | HK$103.43 B | 17,596.57% | 🇺🇸 USA |